These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21120998)

  • 1. Selective estrogen receptor agonism lacks clinical benefit in rheumatoid arthritis: comment on the article by van Vollenhoven et al.
    Cutolo M
    Arthritis Rheum; 2010 Dec; 62(12):3832-3. PubMed ID: 21120998
    [No Abstract]   [Full Text] [Related]  

  • 2. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
    Porter D
    Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
    [No Abstract]   [Full Text] [Related]  

  • 3. Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041.
    Follettie MT; Pinard M; Keith JC; Wang L; Chelsky D; Hayward C; Kearney P; Thibault P; Paramithiotis E; Dorner AJ; Harris HA
    Endocrinology; 2006 Feb; 147(2):714-23. PubMed ID: 16269464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of a prediction rule for disease outcome in patients with undifferentiated arthritis: comment on the article by van der Helm-van Mil et al.
    Visser H; Hazes JM; Luime J
    Arthritis Rheum; 2009 Jul; 60(7):2208-9; author reply 2209-10. PubMed ID: 19565508
    [No Abstract]   [Full Text] [Related]  

  • 5. Severity of rheumatoid arthritis in Portuguese patients: comment on the article by Drosos et al and on the letter by Ronda et al.
    Fonseca JE; Canhão H; Costa Dias F; Leandro MJ; Resende C; Teixeira da Costa JC; Pereira da Silva JA; Viana Queiroz M
    Arthritis Rheum; 2000 Feb; 43(2):470-2. PubMed ID: 10693895
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for interaction between disease severity and comorbidity in rheumatoid arthritis? comment on the article by Navarro-Cano et al.
    Boers M
    Arthritis Rheum; 2004 May; 50(5):1695; author reply 1696-7. PubMed ID: 15146445
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of methotrexate effects and single-nucleotide polymorphisms in the folate pathway in rheumatoid arthritis: comment on the article by Wessels et al.
    Ranganathan P
    Arthritis Rheum; 2006 Oct; 54(10):3372; author reply 3372-3. PubMed ID: 17009311
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor alpha blockade: comment on the article by Buch et al.
    Saxne T; Larsson L; Geborek P
    Arthritis Rheum; 2004 Sep; 50(9):3049-50; author reply 3050-1. PubMed ID: 15457477
    [No Abstract]   [Full Text] [Related]  

  • 9. Is atherosclerosis in rheumatoid arthritis related to disease severity and extraarticular manifestations? Comment on the article by Chung et al.
    Turesson C; Matteson EL
    Arthritis Rheum; 2006 Apr; 54(4):1353; author reply 1353-4. PubMed ID: 16575863
    [No Abstract]   [Full Text] [Related]  

  • 10. Signs of systemic disease are strong determinants of mortality in rheumatoid arthritis: comment on the article by Navarro-Cano et al.
    Turesson C; Matteson EL
    Arthritis Rheum; 2004 May; 50(5):1695-6; author reply 1696-7. PubMed ID: 15146444
    [No Abstract]   [Full Text] [Related]  

  • 11. Rheumatoid arthritis. Outcome measures.
    Paulus HE; Bulpitt KJ
    Rheum Dis Clin North Am; 1995 Aug; 21(3):605-18. PubMed ID: 8619091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al.
    Parker CT; Rennie T
    Arthritis Rheum; 2004 Sep; 50(9):3051; author reply 3051-2. PubMed ID: 15457479
    [No Abstract]   [Full Text] [Related]  

  • 13. The cost-utility analysis of the BeSt trial: is a camel in fact a horse with abnormalities in the distribution of dorsal fat? Comment on the article by van den Hout et al.
    Boers M
    Arthritis Rheum; 2009 Nov; 61(11):1616-7; author reply 1617-8. PubMed ID: 19877096
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
    Raghu P; Grover PS; Kumar A
    Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
    [No Abstract]   [Full Text] [Related]  

  • 15. Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.
    Morgan SL; Baggott JE; Alarcón GS; Koopman WJ
    Arthritis Rheum; 2002 May; 46(5):1413-4. PubMed ID: 12115259
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: comment on the article by Haynes et al.
    Catrina AI; Klareskog L
    Arthritis Rheum; 2008 Nov; 59(11):1685; author reply 1685-6. PubMed ID: 18975354
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the 34C>T variant in the AMPD1 gene on the clinical response to methotrexate in patients with rheumatoid arthritis: comment on the article by Wessels et al.
    Riksen NP; Rongen GA; Smits P; van Riel P; Barrera P
    Arthritis Rheum; 2007 Feb; 56(2):694; author reply 694-5. PubMed ID: 17265507
    [No Abstract]   [Full Text] [Related]  

  • 18. Polymorphism in the stromelysin 1 (matrix metalloproteinase 3) promoter gene and severity of rheumatoid arthritis: comment on the article by Constantin et al.
    Massarotti M; Marasini B; Marchesoni A; Arreghini M; Biondi ML
    Arthritis Rheum; 2003 Sep; 48(9):2695-6. PubMed ID: 13130493
    [No Abstract]   [Full Text] [Related]  

  • 19. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent.
    Hughes ZA; Liu F; Platt BJ; Dwyer JM; Pulicicchio CM; Zhang G; Schechter LE; Rosenzweig-Lipson S; Day M
    Neuropharmacology; 2008 Jun; 54(7):1136-42. PubMed ID: 18423777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The original "DAS" and the "DAS28" are not interchangeable: comment on the articles by Prevoo et al.
    van der Heijde DM; Jacobs JW
    Arthritis Rheum; 1998 May; 41(5):942-5. PubMed ID: 9588750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.